Literature DB >> 32376506

Use of Polygenic Risk Scores to Select Screening Intervals After Negative Findings From Colonoscopy.

Feng Guo1, Korbinian Weigl2, Prudence Rose Carr3, Thomas Heisser1, Lina Jansen3, Philip Knebel4, Jenny Chang-Claude5, Michael Hoffmeister3, Hermann Brenner6.   

Abstract

BACKGROUND & AIMS: Polygenic risk scores (PRSs) could help to define starting ages for colorectal cancer (CRC) screening. However, the role of PRS in determining the length of screening interval after negative findings from colonoscopies is unclear. We aimed to evaluate CRC risk according to PRS and time since last negative colonoscopy.
METHODS: We collected data from 3827 cases and 2641 CRC-free controls in a population-based case-control study in Germany. We constructed a polygenic risk scoring system, based on 90 single-nucleotide polymorphisms, associated with risk of CRC in people of European descent. Participants were classified as having low, medium, or high genetic risk according to tertiles of PRSs among controls. Multiple logistic regression models were used to assess CRC risk according to PRS and time since last negative colonoscopy.
RESULTS: Compared to individuals without colonoscopy in the low PRS category, a 42%-85% lower risk of CRC was observed for individuals who had a negative finding from colonoscopy within 10 years. Beyond 10 years after a negative finding from colonoscopy, significantly lower risk only persisted for the low and medium PRS groups, but not for the high PRS group. Adjusted odds ratios were 0.44 (95% CI, 0.29-0.68), 0.51 (95% CI, 0.34-0.77), and 0.85 (95% CI, 0.58-1.23) in the low, medium, and high PRS group, respectively. Within any time interval, risks were lower for distal than for proximal CRCs.
CONCLUSIONS: Based on findings from a population-based case-control study, the recommended 10-year screening interval for colonoscopy may not need to be shortened among people with high PRSs, but could potentially be prolonged for people with low and medium PRSs. Studies are needed to address personalized time intervals for repeat colonoscopies in average-risk screening cohorts.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal Cancer; Endoscopy; Genetic Variant; SNP

Year:  2020        PMID: 32376506     DOI: 10.1016/j.cgh.2020.04.077

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  4 in total

Review 1.  A scoping review of risk-stratified bowel screening: current evidence, future directions.

Authors:  J M Cairns; S Greenley; O Bamidele; D Weller
Journal:  Cancer Causes Control       Date:  2022-03-20       Impact factor: 2.532

2.  Colorectal Cancer Risk by Genetic Variants in Populations With and Without Colonoscopy History.

Authors:  Feng Guo; Xuechen Chen; Jenny Chang-Claude; Michael Hoffmeister; Hermann Brenner
Journal:  JNCI Cancer Spectr       Date:  2021-01-23

3.  Effects of Screenings in Reducing Colorectal Cancer Incidence and Mortality Differ by Polygenic Risk Scores.

Authors:  Jungyoon Choi; Guochong Jia; Wanqing Wen; Jirong Long; Xiao-Ou Shu; Wei Zheng
Journal:  Clin Transl Gastroenterol       Date:  2021-05-06       Impact factor: 4.396

4.  Polymorphisms within Autophagy-Related Genes Influence the Risk of Developing Colorectal Cancer: A Meta-Analysis of Four Large Cohorts.

Authors:  Juan Sainz; Francisco José García-Verdejo; Manuel Martínez-Bueno; Abhishek Kumar; José Manuel Sánchez-Maldonado; Anna Díez-Villanueva; Ludmila Vodičková; Veronika Vymetálková; Vicente Martin Sánchez; Miguel Inacio Da Silva Filho; Belém Sampaio-Marques; Stefanie Brezina; Katja Butterbach; Rob Ter Horst; Michael Hoffmeister; Paula Ludovico; Manuel Jurado; Yang Li; Pedro Sánchez-Rovira; Mihai G Netea; Andrea Gsur; Pavel Vodička; Víctor Moreno; Kari Hemminki; Hermann Brenner; Jenny Chang-Claude; Asta Försti
Journal:  Cancers (Basel)       Date:  2021-03-12       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.